Kivalliq Health Research Collection: Tuberculosis

Burden of tuberculosis in indigenous peoples globally: a systematic review. (2013). 

Descriptive review of tuberculosis surveillance systems across the circumpolar regions. (2016).

Developing and Field Testing a Community Based Youth Initiative to Increase Tuberculosis Awareness in Remote Arctic Inuit Communities. (2016). 

Diabetes is a risk factor for tuberculosis in the Inuit population of Greenland. (2012). 

Examining DNA fingerprinting as an epidemiology tool in the tuberculosis program in the Northwest Territories, Canada. (2013).Housing and tuberculosis in an Inuit village in northern Quebec: a case-control study. (2016).

The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada. (2015). 

The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community. (2014). 

Inadequate Diet Is Associated with Acquiring Mycobacterium tuberculosis Infection in an Inuit Community. A Case-Control Study. (2015).

Respiratory disease in Canadian First Nations and Inuit children. (2012).

Sputum induction for tuberculosis diagnosis in an Arctic setting: a cost comparison. (2014).

Stochastic agent-based modeling of tuberculosis in Canadian Indigenous communities. (2017).

Taima (stop) TB: the impact of a multifaceted TB awareness and door-to-door campaign in residential areas of high risk for TB in Iqaluit, Nunavut. (2014). 

TB: fighting a forgotten disease in Canada. (2015).

Tuberculosis in Nunavut: looking back, moving forward. (2013).

Xpert(R)MTB/RIF for the Diagnosis of Tuberculosis in a Remote Arctic Setting: Impact on Cost and Time to Treatment Initiation. (2016). 

Intermittent versus daily therapy for treating tuberculosis in children. (2014)

Evidence supports TB test, so what now? (2013). 

Adjunctive steroid therapy for managing pulmonary tuberculosis. (2014).

Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis. (2016).

Nutritional supplements for people being treated for active tuberculosis. (2016). 

Smoking cessation interventions for pulmonary tuberculosis treatment outcomes. (2016).

Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment. (2014). 

Patient education and counselling for promoting adherence to treatment for tuberculosis. (2012).

Corticosteroids for managing tuberculous meningitis. (2016).

Vitamin D supplementation for preventing infections in children under five years of age. (2016).

Fluoroquinolones for treating tuberculosis (presumed drug-sensitive). (2013).

Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines. (2017). 

Diagnosis of active and latent tuberculosis: summary of NICE guidance. (2012).

Guidelines on the Management of Latent Tuberculosis Infection. World Health Organization. (2015).

Nutritional supplements for people being treated for active tuberculosis. (2016). 

Practice guideline for treatment of latent tuberculosis infection in children. (2015).

Protecting health care workers from tuberculosis, 2013: ACOEM Medical Center Occupational Health Section Task Force on Tuberculosis and Health Care Workers. (2013).

Recommendations for the diagnosis of pediatric tuberculosis. (2016).

Systematic Screening for Active Tuberculosis: Principles and Recommendations. World Health Organization. (2013).

Tuberculosis: Prevention, Diagnosis, Management and Service Organisation. ​(2016).

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update. World Health Organization. (2016).​